Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Suven Pharmaceuticals Ltd. ( (IN:SUVENPHAR) ) just unveiled an update.
Suven Pharmaceuticals Ltd. has received a cautionary email from BSE regarding a delay in notifying the stock exchanges about the appointment of their Statutory Auditors, which should have been communicated within 30 minutes of the board meeting conclusion. Despite this oversight, the company assures stakeholders that there is no impact on its financial, operational, or other activities, and it commits to adhering to SEBI’s disclosure requirements in the future.
More about Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients and intermediates. The company is based in India with offices in Mumbai and Hyderabad, and it is listed on major stock exchanges such as BSE and NSE.
YTD Price Performance: -4.40%
Average Trading Volume: 13,045
Current Market Cap: 295.2B INR
See more insights into SUVENPHAR stock on TipRanks’ Stock Analysis page.